ClinicalTrials.gg
Sign In

Hyperuricemia clinical trials

The registry lists 240 studies for Hyperuricemia across more than 10 countries. 44 are recruiting or about to start. 111 of them are mainly about Hyperuricemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.

Get an email when these change. Save the Hyperuricemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
132
Status unknown
38
Recruiting
29
Active, not recruiting
14
Not yet recruiting
13
Terminated
9

Phase

Phase 2
67
Phase 1
42
Phase 4
28
Phase 3
23
Early Phase 1
4

Where

United States
75
China
57
Japan
17
Taiwan
14
France
7
Italy
6

Who runs them

Jiangsu HengRui Medicine Co., Ltd. (14) · LG Chem (10) · Sanofi (8) · Takeda (7) · Arthrosi Therapeutics (6) · Sun Yat-sen University (6) · Allena Pharmaceuticals (5) · Assiut University (5)

What is being tested here

Drugs under test in Hyperuricemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dotinurad327
Febuxostat2326
Allopurinol1217
Ruzinurad1011
Mazdutide101
Empagliflozin101
Dapansutrile111
Sodium Bicarbonate101
Potassium Citrate101
Citric Acid101

Coming up

5phase 3 studies under way
16studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 29 Hyperuricemia studies recruiting now, 8 (28%) set no upper age limit and 13 (45%) stop at 75 or younger. 1 (3%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 6 (21%) take healthy volunteers.

Recruiting studies that take each age, of 29
AgeWomenMen
101 (3%)1 (3%)
1825 (86%)25 (86%)
3026 (90%)26 (90%)
4028 (97%)28 (97%)
5028 (97%)28 (97%)
6528 (97%)28 (97%)
7521 (72%)21 (72%)
859 (31%)9 (31%)

Across all 240 studies, recruiting or not: 62% stop at 75 or younger and 36% at 65; 5% take children; 1% are for women only and 8% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperuricemia studies take

Of 31 phase 1 interventional studies under Hyperuricemia, half reached primary completion within 6 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 16 mo1–10 · 31 studies4 mo1–9 · 29 studies—
Phase 214 mo10–26 · 24 studies——
Interventional, no phase14 mo6–34 · 26 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 240. Browse all 240 → or search them.